Fortunately, science has a cure for troublesome moderate to severe glabellar lines, also known as frown lines. What is a glabellar line? These are the troublesome little wrinkles between the eyebrows that won’t disappear. New FDA-approved Jeuveau is an injectable treatment that temporarily softens the appearance of frown lines in adults.
Jeuveau is a prescription drug that is injected into muscles and used to improve the appearance of moderate to severe frown lines between the brows.
Rejuvenate Medical Spa, led by Dr. Bijan Farah, provides cosmetic injectable med spa treatments to patients in Encino, Sherman Oaks, San Fernando, Calabasas, Woodland Hills, Tarzana, Los Angeles, CA, and surrounding communities.
Highlights
- Proven molecular structure: Jeuveau is a 900kDa purified botulinum toxin type A
- Hi-Pure technology
- Produced a modern manufacturing process.
- Cosmetic-first and only
- Clinically developed solely for aesthetics, Jeuveau is meant exclusively for cosmetics and nothing else.
Research Studies - Proven Outcomes
Jeuveau is a modern-made neurotoxin that is manufactured in a highly advanced production process. This drug has been studied in more than 2,100 patients across five clinical studies. The most frequently occurring side effects reported in clinical trials are eyelid drooping, upper respiratory tract infection, headache, and increased white blood cell count. There have not been any serious medication-related side effects in the studies.Frequently Asked Questions
What exactly is Jeuveau? Glabellar lines or “frown lines” are the pesky little wrinkles between the eyebrows that just refuse to go away. Jeuveau is an injectable treatment that can temporarily soften the appearance of moderate to severe glabellar lines in adults. How does Jeuveau work? Jeuveau disrupts communication from the nerves telling the facial muscles to flex. The outcome? Clinical trials show that Jeuveau temporarily improved the appearance of moderate to severe frown lines. The results of two long-term safety studies indicate that patients received an average of three treatments over the span of one year. What are the outcomes with Jeuveau? In two major clinical trials, when researchers evaluated at the 30-day mark, 67.5 percent of patients in one study and 70.4 percent of participants in a second study were responders defined as a 2-point composite improvement agreed upon by doctor and patient. What is it like before and after treatment? People undergoing treatment for the first time may be understandably anxious. Infection, localized pain, swelling, tenderness, erythema, and/or bleeding/bruising may be a side-effect of the injections. Patients should follow the guidelines given to them by their doctor or medical care provider to understand exactly what to do before and after their injection. What are the side effects? In clinical trials, the most commonly reported side effects include upper respiratory tract infection, eyelid drooping, headache, and increased white blood cell count. No serious side effects associated with the drug were seen in the trials.Caution
Patients should inform their medical care provider about all their nerve or muscle conditions such as Myasthenia gravis, ALS or Lou Gehrig’s disease, or Lambert-Eaton syndrome. Such patients may be at a higher risk of serious side effects, including problems in swallowing as well as difficulty breathing from typical doses of Jeuveau. Patients should inform their healthcare provider about all their medical conditions, including:- Any side effects of botulinum toxin products, such as breathing, bleeding, swallowing, or heart problems
- Drooping eyelids
- Pregnant or breastfeeding, or plan to become pregnant or breastfeed
